• Home
  • News
  • Fortune 500
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
    • Great Place to Work
  • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Investing
    • Banking
    • Crypto
  • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Home
  • News
  • FORTUNE 500
    • FORTUNE 500
    • FORTUNE SEA 500
    • Fortune 500 Europe
    • Fortune Global 500
    • Fortune China 500
    • Great Place to Work
  • Tech
    • Tech
    • AI
    • Innovation
    • Cybersecurity
  • Finance
    • Finance
    • Personal Finance
    • Real Estate
    • Economy
    • Banking
    • Investing
    • Crypto
  • Leadership
    • Leadership
    • Success
    • Future of Work
    • Workplace Culture
    • C-Suite
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Travel & Leisure
    • Health
    • Well
    • Education
  • Rankings
    • Rankings
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Video
    • Podcasts
  • Asia
  • Europe
  • Analytics
  1. home
  1. home
  2. BioNTech

BioNTech

Page 6 of 6

A volunteer receives an injection from a medical worker during the country's first human clinical trial for a potential vaccine against COVID-19 at the Baragwanath Hospital on June 28, 2020 in Soweto, South Africa.
Health

How to stop vaccine nationalism from prolonging the pandemic

By David Meyer
February 7, 2021
01 February 2021, Lower Saxony, Lingen: Senior citizen Maria Hesemann-Peters is vaccinated against the corona virus with the active ingredient from Biontech/Pfizer by emergency paramedic Bernd Rode from the DRK (German Red Cross) at the vaccination centre in the Emslandhallen.
Health

Why Europe’s summer COVID vaccination target could still be on track

By David Meyer
February 1, 2021
Tom Richmond receives his AstraZeneca/Oxford University Covid-19 vaccine from Vaccinator Louise Chadwick at Acklam Road pharmacy on January 28, 2021 in Middlesbrough, England.
Health

With supplies running low, Europe approves AstraZeneca’s COVID-19 vaccine for all adults

By Jeremy Kahn and David Meyer
January 29, 2021
An NHS staff member prepares an AstraZeneca Covid-19 vaccination as over-eighty year olds receive their vaccinations on January 26, 2021 at Stithians Showground, near Truro, England.
Health

Furious at AstraZeneca, the EU plans export controls for COVID vaccines made on its home turf

By David Meyer
January 26, 2021
No direct link between the COVID vaccine and a recent string of deaths in the elderly, Norway finds
Health

No direct link between the COVID vaccine and a recent string of deaths in the elderly, Norway finds

By Lars Erik Taraldsen and Bloomberg
January 18, 2021
Public health officials warn about slow vaccine rollout as coronavirus variants multiply
Health

Public health officials warn about slow vaccine rollout as coronavirus variants multiply

By James Paton and Bloomberg
January 18, 2021
Sick patients over 80 could be a COVID vaccine risk, Norwegian health officials warn
Health

Sick patients over 80 could be a COVID vaccine risk, Norwegian health officials warn

By Lars Erik Taraldsen, Naomi Kresge and Bloomberg
January 15, 2021
Drugmakers hit back at U.K. plan to delay the second dose of COVID vaccines
Health

Drugmakers hit back at U.K. plan to delay the second dose of COVID vaccines

By James Paton and Bloomberg
January 13, 2021
EU regulators approve Moderna’s COVID vaccine as pressure builds to speed up immunizations
Health

EU regulators approve Moderna’s COVID vaccine as pressure builds to speed up immunizations

By Naomi Kresge and Bloomberg
January 6, 2021
An Israeli military medic gets vaccinated against the COVID-19 coronavirus at the medical centre of Tzrifin military base in the Israeli town of Rishon Lezion on December 28, 2020.
Health

Israel built the world’s best COVID vaccination program, but that’s unlikely to save it from new lockdown measures

By David Meyer
January 5, 2021
EU seeks an additional 300 million Pfizer-BioNTech vaccine doses
Health

EU seeks an additional 300 million Pfizer-BioNTech vaccine doses

By Naomi Kresge, John Follain and Bloomberg
January 5, 2021

Most Popular

  • AI
    'Godfather of AI' says the technology will create massive unemployment and send profits soaring — 'that is the...
    By Jason Ma
  • Success
    This Stanford computer science professor went to written exams 2 years ago because of AI. He says his students insisted...
    By Nick Lichtenberg
  • Economy
    Top analyst says you weren't crazy for thinking the economy felt worse than it looked the last 3 years. The 'rolling...
    By Nick Lichtenberg
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.